Ligand Pharmaceuticals Inc (LGND)
EBITDA Growth
247.01%
Quarterly · Period ending:
LGND EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported247.01%period ending
Latest reported247.01%period ending
LGND Quarterly EBITDA YoY % (34.62% → 247.01%)
Year-over-year change
High-resolution chart · PNG
LGND ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 247.0141% | |
| 64.7387% | |
| 323.6578% | |
| 4,299.47% | |
| 137.8114% | |
| -133.1361% | |
| -211.3737% | |
| 196.1495% | |
| -526.7876% | |
| 87.2473% | |
| -59.7554% | |
| -113.4855% | |
| -45.4737% | |
| 863.9032% | |
| 835.197% | |
| 6.8192% | |
| -0.7563% | |
| -72.5413% | |
| -68.626% | |
| 3,184.1509% | |
| -37.9286% | |
| 259.4111% | |
| -0.5243% | |
| 65.9383% | |
| 1,899.0667% | |
| -101.8077% | |
| 168.053% | |
| -102.4274% | |
| -102.9282% | |
| 1,299.9591% | |
| -188.7579% | |
| 446.3435% | |
| 414.4524% | |
| 363.7742% | |
| 67.0505% | |
| 109.5119% | |
| 109.7611% | |
| -25.3296% | |
| 88.4226% | |
| -12.3722% | |
| 29.6998% | |
| 318.5457% | |
| 9.9374% | |
| 119.1086% | |
| 141.7476% | |
| -29.3034% | |
| 49.1074% | |
| 10.3405% | |
| -20.096% | |
| 27.3076% | |
| 37.474% | |
| 736.4366% | |
| 256.474% | |
| 6,439.1892% | |
| -28.4479% | |
| 81.6711% | |
| -270.4497% | |
| 96.6637% | |
| 282.3848% | |
| 78.3158% | |
| 83.363% | |
| 44.9081% | |
| -487.6791% | |
| -944.1034% | |
| 23.3897% | |
| 37.7647% | |
| 101.491% | |
| 134.1172% | |
| 34.9547% | |
| 45.6341% | |
| -814.6002% | |
| 34.6186% | |
| 58.0503% | |
| 57.6985% | |
| -201.2662% | |
| 54.4659% | |
| -0.0223% | |
| -193.4077% | |
| 85.0171% | |
| -11,671.519% | |
| -652.9445% | |
| 15.2418% | |
| 116.8774% | |
| 101.3463% | |
| 88.4789% | |
| 25.9412% | |
| -270.6085% | |
| -151.6835% | |
| -179.8553% | |
| -70.9154% | |
| 438.1326% | |
| 7.0004% | |
| 28.7004% | |
| -1,135.9613% | |
| -246.1349% | |
| -75.9916% | |
| -33.036% | |
| 89.1588% | |
| 92.0262% | |
| 72.7003% |